Close menu




 

Armin Schulz

  • IT
  • Trading
  • Technology

Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.

After graduating, he worked as an IT consultant for a listed company before becoming self-employed, during which time he worked for various DAX-listed companies and a large Swiss insurance company, among others.
Since 2009, he has been exclusively involved in the capital markets, where he was able to gain experience as a day and swing trader, in investor relations and at board level. He was able to live out his passion for numbers in the controlling department of a securities trading house.

For him, fundamental analysis paired with the correct reading of the price action of a market provides the basis for successful trading.


Commented by Armin Schulz

Commented by Armin Schulz on April 8th, 2025 | 07:10 CEST

Palantir US-Tech stocks plummet – MiMedia defies the storm, Xiaomi makes strategic decisions

  • Technology
  • Software
  • Investments

The global financial markets are undergoing an unprecedented stress test. The latest tariff measures by the Trump administration have ignited a trade conflict that is putting technology companies at the center of the turbulence. While US companies such as Apple and Nvidia are suffering from supply chain disruptions and plunging share prices, the technology sector is on the brink of a turning point. However, not all players are reacting in the same way. Palantir shares have recently plummeted, while MiMedia, a cloud specialist, is successfully focusing on disruptive business models – and Xiaomi is demonstrating resilience. In this environment, we take a closer look at the individual stocks.

Read

Commented by Armin Schulz on April 4th, 2025 | 07:10 CEST

Bayer's cancer drugs, Defence Therapeutics' cancer vaccine, Novo Nordisk's fat burner – Back on the road to success through specialization

  • Biotechnology
  • Biotech
  • Pharma

The new trade tariffs threaten to destabilize the global supply chains of the pharmaceutical industry, increase the prices of generic drugs, and slow innovation cycles. The only winners in this environment will be those who focus on unique innovations to ensure resilience and growth. Bayer is trying to make itself fit for the future with an efficiency program, new pharmaceutical products, and digital agriculture platforms. Defence Therapeutics excels with precision-medicine cancer vaccines based on patented technology, opening up new markets. Novo Nordisk, in turn, is shaping a multibillion-dollar market with GLP-1 therapies for obesity and diabetes based on closed production cycles. These three approaches show how specialization and adaptability open new paths in turbulent times.

Read

Commented by Armin Schulz on April 3rd, 2025 | 07:30 CEST

Tungsten shortage as a goldmine: Why Almonty Industries is becoming a key player for NATO countries

  • Mining
  • Tungsten

As early as the beginning of December 2024, there were initial indications that China would impose certain restrictions on its tungsten exports. After the Chinese government further tightened export control on tungsten and molybdenum in early February 2025, Western industries have been increasingly seeking reliable alternatives. While Beijing leverages its dominance in critical metals as a geopolitical lever, companies like Almonty Industries are benefiting by building independent supply chains. With strategic partnerships, a relocation of its headquarters to the US, and the revival of one of South Korea's largest tungsten mines, the Company is positioning itself as a key player in a market characterized by scarcity and increasing demand.

Read

Commented by Armin Schulz on April 2nd, 2025 | 07:20 CEST

dynaCERT: Government-backed, certified, profitable – Driving your returns green

  • Hydrogen
  • GreenTech
  • cleantech
  • greenhydrogen

The Ontario government is leading by example – and dynaCERT could be one of the beneficiaries. The Canadian cleantech company, known for its revolutionary HydraGEN™ technology, is receiving government support in a market that is hungry for solutions for more efficient mobility and measurable CO₂ reductions. In an era when climate goals and economic considerations can no longer be at odds, dynaCERT is positioning itself as a bridge between ecology and economy. A new player is emerging here in the billion-dollar market for emission certificates.

Read

Commented by Armin Schulz on April 2nd, 2025 | 07:10 CEST

Steyr Motors, Power Metallic Mines, BYD – From unique selling point to market leader

  • Mining
  • Nickel
  • Copper
  • rawmaterials
  • Electromobility
  • Defense

In the context of geopolitical tariffs and green transformation, drive technology, raw material extraction, and e-mobility are merging into key sectors. While US automotive tariffs are setting new rules from 2025, three players are driving systemic solutions: Steyr Motors, a pioneer in high-performance hybrid engines; Power Metallic Mines, which is setting ESG standards with carbon-neutral nickel; and BYD, which is dominating e-mobility through innovation. Their strategies – technological sovereignty, vertical integration, and resource-efficient ecosystems – demonstrate how the apparent contradictions between decarbonization and industrial reality can be overcome. Three companies, one mission: to shape the value chain of tomorrow.

Read

Commented by Armin Schulz on April 2nd, 2025 | 07:00 CEST

RENK – The armaments hype is waning. First Phosphate and Volkswagen are taking advantage of the upswing in electromobility!

  • Mining
  • phosphate
  • Defense
  • Electromobility

The demand for armaments stocks is waning. Despite record orders for tank transmissions from the RENK Group and global security investments, the defense boom is flattening out - partly because these stocks have become fundamentally expensive. At the same time, electromobility is gathering pace: The EU predicts a 38% increase in the number of electric vehicles registered in 2025, driven by Germany's planned tax breaks and subsidies for hybrids. This surge requires raw materials to produce lithium iron phosphate batteries, which is where First Phosphate comes into play. Meanwhile, Volkswagen is currently exploring the production of military vehicles, but is also pushing into the market with new electric vehicles and charging systems. Investments for the future should flow into green technologies, not tank production.

Read

Commented by Armin Schulz on March 31st, 2025 | 07:00 CEST

BYD in the fast lane! The gold rally is boosting Benton Resources and Barrick Gold

  • Mining
  • Gold
  • Copper
  • Electromobility

Inflation is driving the markets, and debt mountains are growing – yet amidst the chaos, two commodities are shining: gold as a safe haven and copper, the secret driver of the energy transition. With the best conductivity after silver, copper is indispensable for e-vehicles, power grids, electricity storage, and renewable energies. While gold is chasing new records, the future of electrification is being decided on the copper front. Three companies are currently in the spotlight. BYD, a pioneer in electromobility; Benton Resources, a promising copper and gold explorer; and Barrick Gold, one of the largest gold producers, a beneficiary of the precious metal rally. Where does the greatest potential lie?

Read

Commented by Armin Schulz on March 28th, 2025 | 07:10 CET

ProSiebenSat.1, naoo, Alibaba – Different business models but one goal: Profit amid change

  • Digitization
  • Technology
  • Media
  • ecommerce

The global economy is undergoing a restless transformation. Technological progress, social upheaval, and global networking are challenging companies to rethink their strategies. Digital platforms dominate markets, while sustainability and resilience are becoming decisive competitive advantages. In this field of tension between innovation and tradition, established industries are fighting for survival while new players disrupt the status quo. How can companies succeed in a hybrid world of local values and global reach? Three examples – media giant ProSiebenSat.1, tech startup naoo, which connects the digital world with local retail, and e-commerce giant Alibaba – demonstrate how differently the future can be shaped.

Read

Commented by Armin Schulz on March 26th, 2025 | 07:10 CET

Volkswagen, European Lithium, BYD – Lithium as a winner in the crisis: Why analysts are predicting a rally despite the chaos

  • mining
  • Lithium
  • Electromobility
  • Batteries
  • Commodities

The global energy transition is catapulting lithium into the spotlight. As an indispensable raw material for batteries, the electrification of mobility and energy infrastructure has fueled demand enormously. But after the hype, prices plunged from record highs to below USD 10,000. Now, there are increasing signs of a trend reversal: Production cutbacks, a predicted demand explosion of around 20% this year, strategic investments by large corporations, and technological leaps in extraction could curb the oversupply. Is lithium on the verge of returning as the scarce "white gold"? The stage seems to be set for a revaluation of the market.

Read

Commented by Armin Schulz on March 25th, 2025 | 07:10 CET

Evotec, NetraMark, Novo Nordisk – From the lab to a golden digital future with artificial intelligence

  • Biotechnology
  • Biotech
  • Pharma
  • AI

The pharmaceutical industry is experiencing a revolution that is changing everything! Artificial intelligence is sweeping through laboratories and breaking with old habits. Algorithms scour billions of chemical structures in record time, uncovering hidden treasures of active ingredients. While years used to pass before a drug entered the testing phase, AI models are now picking up the pace. Heavyweights like AstraZeneca are in a neck-and-neck race with start-ups. Who will be the first to crack incurable diseases? The goal is to tailor therapies, revolutionize clinical studies, and save lives. Only those who use AI will remain competitive and be able to offer patients innovative drugs faster. The era of data-driven medicine has begun.

Read